1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	408_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	408_QUEST_clinical_caseMIR	SENT1	-	-
3	45	45		-	-	9-11	408_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	408_QUEST_clinical_caseMIR	SENT1	-	-
5	diagnosticada	diagnosticar	VMP00SF	-	-	17-30	408_QUEST_clinical_caseMIR	SENT1	-	-
6	de	de	SPS00	C0332285	atributo	31-33	408_QUEST_clinical_caseMIR	SENT1	-	-
7	linfoma	linfoma	NCMS000	C0024301_1	anomalía_morfológica_1	34-41	408_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
8	folicular	folicular	NC00SC0	C0024301_2	anomalía_morfológica_2	42-51	408_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
9	y	y	CC	C1706368	calificador	52-53	408_QUEST_clinical_caseMIR	SENT1	-	-
10	en	en	SPS00	C1720294#C0332285	calificador#atributo	54-56	408_QUEST_clinical_caseMIR	SENT1	-	-
11	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	57-68	408_QUEST_clinical_caseMIR	SENT1	-	-
12	con	con	SPS00	C0332287	atributo	69-72	408_QUEST_clinical_caseMIR	SENT1	-	-
13	poliquimioterapia	poliquimioterapia	NCFS000	-	-	73-90	408_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
14	(	(	Fpa	-	-	91-92	408_QUEST_clinical_caseMIR	SENT1	-	-
15	R-CHOP	r-chop	NCMS000	-	-	92-98	408_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
16	)	)	Fpt	-	-	98-99	408_QUEST_clinical_caseMIR	SENT1	-	-
17	.	.	Fp	-	-	99-100	408_QUEST_clinical_caseMIR	SENT1	-	-

1	Ingresa	ingresar	VMIP3S0	-	-	101-108	408_QUEST_clinical_caseMIR	SENT2	-	-
2	por	por	SPS00	C0678226	atributo	109-112	408_QUEST_clinical_caseMIR	SENT2	-	-
3	dolor	dolor	NCMS000	C0008033_1	hallazgo_1	113-118	408_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
4	pleurítico	pleurítico	NCMS000	C0008033_2	hallazgo_2	119-129	408_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
5	en	en	SPS00	C1720294#C0332285	calificador#atributo	130-132	408_QUEST_clinical_caseMIR	SENT2	-	-
6	costado	costado	NCMS000	-	-	133-140	408_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
7	izquierdo	izquierdo	AQ0MS0	C0205091	calificador	141-150	408_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
8	.	.	Fp	-	-	150-151	408_QUEST_clinical_caseMIR	SENT2	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	152-154	408_QUEST_clinical_caseMIR	SENT3	-	-
2	la	el	DA0FS0	-	-	155-157	408_QUEST_clinical_caseMIR	SENT3	-	-
3	radiografía	radiografía	NCFS000	C0039985_1	procedimiento_1	158-169	408_QUEST_clinical_caseMIR	SENT3	-	-
4	de	de	SPS00	C0039985_2	procedimiento_2	170-172	408_QUEST_clinical_caseMIR	SENT3	-	-
5	tórax	tórax	NCMN000	C0039985_3	procedimiento_3	173-178	408_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
6	se	se	P00CN000	-	-	179-181	408_QUEST_clinical_caseMIR	SENT3	-	-
7	evidencia	evidenciar	VMIP3S0	-	-	182-191	408_QUEST_clinical_caseMIR	SENT3	-	-
8	un	un		C0205447_1	calificador_1	192-194	408_QUEST_clinical_caseMIR	SENT3	-	-
9	derrame	derrame	NCMS000	C0032227_1	trastorno_1	195-202	408_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
10	pleural	pleural	NC00SC0	C0032227_2	trastorno_2	203-210	408_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
11	de	de	SPS00	C0332285	atributo	211-213	408_QUEST_clinical_caseMIR	SENT3	-	-
12	moderada	moderar	VMP00SF	-	-	214-222	408_QUEST_clinical_caseMIR	SENT3	-	-
13	cuantía	cuantía	NCFS000	-	-	223-230	408_QUEST_clinical_caseMIR	SENT3	-	-
14	y	y	CC	C1706368	calificador	231-232	408_QUEST_clinical_caseMIR	SENT3	-	-
15	en	en	SPS00	C1720294#C0332285	calificador#atributo	233-235	408_QUEST_clinical_caseMIR	SENT3	-	-
16	la	el	DA0FS0	-	-	236-238	408_QUEST_clinical_caseMIR	SENT3	-	-
17	toracocentesis	toracocentesis	NC00SC0	C0189477	procedimiento	239-253	408_QUEST_clinical_caseMIR	SENT3	-	-
18	se	se	P00CN000	-	-	254-256	408_QUEST_clinical_caseMIR	SENT3	-	-
19	comprueba	comprobar	VMIP3S0	-	-	257-266	408_QUEST_clinical_caseMIR	SENT3	-	-
20	un	un		C0205447_1	calificador_1	267-269	408_QUEST_clinical_caseMIR	SENT3	-	-
21	exudado	exudado	NCMS000	C0015388#C0311437	sustancia#anomalía_morfológica#función	270-277	408_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
22	serohemorrágico	serohemorrágico	AQ0MS00	-	-	278-293	408_QUEST_clinical_caseMIR	SENT3	B-Calificador	-
23	con	con	SPS00	C0332287	atributo	294-297	408_QUEST_clinical_caseMIR	SENT3	-	-
24	12.000	12.000		-	-	298-304	408_QUEST_clinical_caseMIR	SENT3	-	-
25	leucocitos/_x001F_L	leucocitos/_x001F_L		-	-	305-324	408_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
26	con	con	SPS00	C0332251_1	calificador_1	325-328	408_QUEST_clinical_caseMIR	SENT3	-	-
27	predominio	predominio	NCMS000	C0332251_2	calificador_2	329-339	408_QUEST_clinical_caseMIR	SENT3	-	-
28	de	de	SPS00	C0332251_3	calificador_3	340-342	408_QUEST_clinical_caseMIR	SENT3	-	-
29	neutrófílos	neutrófílos	NCMP000	-	-	343-354	408_QUEST_clinical_caseMIR	SENT3	-	-
30	y	y	CC	C1706368	calificador	355-356	408_QUEST_clinical_caseMIR	SENT3	-	-
31	ausencia	ausencia	NCFS000	C0332197_1	calificador_1	357-365	408_QUEST_clinical_caseMIR	SENT3	-	-
32	de	de	SPS00	C0332197_2	calificador_2	366-368	408_QUEST_clinical_caseMIR	SENT3	-	-
33	células	célula	NCFP000	C1269647#C0007634	célula#estructura_corporal	369-376	408_QUEST_clinical_caseMIR	SENT3	-	-
34	mesoteliates	mesoteliates	NCMP000	-	-	377-389	408_QUEST_clinical_caseMIR	SENT3	-	-
35	.	.	Fp	-	-	389-390	408_QUEST_clinical_caseMIR	SENT3	-	-

1	La	el	DA0FS0	-	-	391-393	408_QUEST_clinical_caseMIR	SENT4	-	-
2	tinción	tinción	NCFS000	C0038128#C0013343	sustancia	394-401	408_QUEST_clinical_caseMIR	SENT4	-	-
3	de	de	SPS00	C0332285	atributo	402-404	408_QUEST_clinical_caseMIR	SENT4	-	-
4	Ziehl	ziehl	NCMS000	-	-	405-410	408_QUEST_clinical_caseMIR	SENT4	-	-
5	y	y	CC	C1706368	calificador	411-412	408_QUEST_clinical_caseMIR	SENT4	-	-
6	el	el	DA0MS0	-	-	413-415	408_QUEST_clinical_caseMIR	SENT4	-	-
7	cultivo	cultivo	NCMS000	C0200953_1	procedimiento_1	416-423	408_QUEST_clinical_caseMIR	SENT4	-	-
8	de	de	SPS00	C0200953_2	procedimiento_2	424-426	408_QUEST_clinical_caseMIR	SENT4	-	-
9	micobacterias	micobacterias		C0200953_3	procedimiento_3	427-440	408_QUEST_clinical_caseMIR	SENT4	-	-
10	fueron	ser	VSIS3P0	-	-	441-447	408_QUEST_clinical_caseMIR	SENT4	-	-
11	negativos	negativo	AQ0MP0	C0205160#C0549184	calificador	448-457	408_QUEST_clinical_caseMIR	SENT4	-	-
12	y	y	CC	C1706368	calificador	458-459	408_QUEST_clinical_caseMIR	SENT4	-	-
13	la	el	DA0FS0	-	-	460-462	408_QUEST_clinical_caseMIR	SENT4	-	-
14	adenosindeaminasa	adenosindeaminasa	NCFS000	-	-	463-480	408_QUEST_clinical_caseMIR	SENT4	-	-
15	en	en	SPS00	C1720294#C0332285	calificador#atributo	481-483	408_QUEST_clinical_caseMIR	SENT4	-	-
16	liquido	liquidar	VMIP1S0	-	-	484-491	408_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
17	pleural	pleural	NC00SC0	C1522720	calificador	492-499	408_QUEST_clinical_caseMIR	SENT4	I-Estructura_Corporal	-
18	estaba	estar	VAII3S0	-	-	500-506	408_QUEST_clinical_caseMIR	SENT4	-	-
19	ligeramente	ligeramente	RG	C0750482	calificador	507-518	408_QUEST_clinical_caseMIR	SENT4	-	-
20	elevada	elevar	VMP00SF	-	-	519-526	408_QUEST_clinical_caseMIR	SENT4	-	-
21	.	.	Fp	-	-	526-527	408_QUEST_clinical_caseMIR	SENT4	-	-

1	De	de	SPS00	C0332285	atributo	528-530	408_QUEST_clinical_caseMIR	SENT5	-	-
2	las	el	DA0FP0	-	-	531-534	408_QUEST_clinical_caseMIR	SENT5	-	-
3	siguientes	siguiente	AQ0CP0	C0332282	atributo	535-545	408_QUEST_clinical_caseMIR	SENT5	-	-
4	,	,	Fc	-	-	545-546	408_QUEST_clinical_caseMIR	SENT5	-	-
5	¿	¿	Fia	-	-	547-548	408_QUEST_clinical_caseMIR	SENT5	-	-
6	cuál	cuál	PT0CS000	-	-	548-552	408_QUEST_clinical_caseMIR	SENT5	-	-
7	sería	ser	VSIC1S0	-	-	553-558	408_QUEST_clinical_caseMIR	SENT5	-	-
8	la	el	DA0FS0	-	-	559-561	408_QUEST_clinical_caseMIR	SENT5	-	-
9	prueba	prueba	NCFS000	-	-	562-568	408_QUEST_clinical_caseMIR	SENT5	-	-
10	diagnóstica	diagnóstico	AQ0FS0	C0011900	entidad_observable	569-580	408_QUEST_clinical_caseMIR	SENT5	-	-
11	más	más	RG	C0205172	calificador	581-584	408_QUEST_clinical_caseMIR	SENT5	-	-
12	rentable	rentable	AQ0CS0	-	-	585-593	408_QUEST_clinical_caseMIR	SENT5	-	-
13	?	?	Fit	-	-	593-594	408_QUEST_clinical_caseMIR	SENT5	-	-

